Indian Journal of Pharmacy and Pharmacology
  • Year: 2016
  • Volume: 3
  • Issue: 4

Steven-Johnson Syndrome following Sodium Valproate Monotherapy

  • Author:
  • Jitendra Singh1, Kamlesh K Gupta2, Anju Dinkar3,, Virendra Atam4, Ravi Mishra5
  • Total Page Count: 2
  • Page Number: 227 to 228

1Senior Resident, Dept. of Medicine, King George Medical University, Lucknow

2Associate Professor, Dept. of Medicine, King George Medical University, Lucknow

3Assistant Professor, Dept. of Microbiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi

4Professor, Dept. of Medicine, King George Medical University, Lucknow

5Professor & HOD, Dept. of Medicine, King George Medical University, Lucknow

*Corresponding Author: Email: dranjudinkar@gmail.com

Online published on 23 June, 2017.

Abstract

Steven-Johnson Syndrome (SJS) is a severe, episodic, acute mucocutaneous reaction characterized by blisters and epidermal detachment resulting from epidermal necrosis in the absence of substantial dermal inflammation. We report a case of 64-year old male farmer who developed Stevens-Johnson syndrome following the ingestion of Sodium Valproate monotherapy prescribed for seizure disorder. He was treated with intravenous corticosteroids, antihistamine, antibiotics and supportive therapy. We are presenting this case to highlight the serious adverse effect of commonly prescribed antiepileptic drug, sodium valproate as a monotherapy.

Keywords

Sodium Valproate, Steven-Johnson Syndrome, Seizure Disorder, Mucocutaneous reaction, Corticosteroid